HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.

Abstract
Emerging studies show that long noncoding RNAs (lncRNAs) have important roles in carcinogenesis. lncRNA ZEB1 antisense 1 (ZEB1-AS1) is a novel lncRNA, whose clinical significance, biological function, and underlying mechanism remains unclear in glioma. Here, we found that ZEB1-AS1 was highly expressed in glioma tissues, being closely related to clinical stage of glioma. Moreover, patients with high ZEB1-AS1 levels had poor prognoses, with the evidence provided by multivariate Cox regression analysis indicating that ZEB1-AS1 expression could serve as an independent prognostic factor in glioma patients. Functionally, silencing of ZEB1-AS1 could significantly inhibit cell proliferation, migration, and invasion, as well as promote apoptosis. Knockdown of ZEB1-AS1 significantly induced the G0/G1 phase arrest and correspondingly decreased the percentage of S phase cells. Further analysis indicated that ZEB1-AS1 could regulate the cell cycle by inhibiting the expression of G1/S transition key regulators, such as Cyclin D1 and CDK2. Furthermore, ZEB1-AS1 functioned as an important regulator of migration and invasion via activating epithelial to mesenchymal transition (EMT) through up-regulating the expression of ZEB1, MMP2, MMP9, N-cadherin, and Integrin-β1 as well as decreasing E-cadherin levels in the metastatic progression of glioma. Additionally, forced down-regulation of ZEB1-AS1 could dramatically promote apoptosis by increasing the expression level of Bax and reducing Bcl-2 expression in glioma. Taken together, our data suggest that ZEB1-AS1 may serve as a new prognostic biomarker and therapeutic target of glioma.
AuthorsQiao-Li Lv, Lei Hu, Shu-Hui Chen, Bao Sun, Meng-Long Fu, Chong-Zhen Qin, Qiang Qu, Gui-Hua Wang, Chen-Jie He, Hong-Hao Zhou
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 17 Issue 9 (Aug 30 2016) ISSN: 1422-0067 [Electronic] Switzerland
PMID27589728 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Cadherins
  • RNA, Long Noncoding
  • ZEB1 protein, human
  • Zinc Finger E-box-Binding Homeobox 1
  • long non-coding RNA ZEB1-AS1, human
  • Cyclin D1
  • CDK2 protein, human
  • Cyclin-Dependent Kinase 2
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • MMP9 protein, human
  • Matrix Metalloproteinase 9
Topics
  • Adult
  • Apoptosis
  • Biomarkers, Tumor (genetics, metabolism)
  • Brain Neoplasms (genetics, metabolism, pathology)
  • Cadherins (genetics, metabolism)
  • Carcinogenesis (genetics, metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Cyclin D1 (genetics, metabolism)
  • Cyclin-Dependent Kinase 2 (genetics, metabolism)
  • Epithelial-Mesenchymal Transition
  • Female
  • G1 Phase Cell Cycle Checkpoints
  • Glioma (genetics, metabolism, pathology)
  • Humans
  • Male
  • Matrix Metalloproteinase 2 (genetics, metabolism)
  • Matrix Metalloproteinase 9 (genetics, metabolism)
  • Middle Aged
  • RNA, Long Noncoding (genetics, metabolism)
  • Zinc Finger E-box-Binding Homeobox 1 (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: